Updated:
LENSAR
LENSAR builds robotic cataract laser systems for refractive surgeons from its Orlando headquarters, with offices in Irvine and Hong Kong.
LENSAR
LENSAR is a medical technology company headquartered in Orlando, Florida, with offices in Irvine, California, and Hong Kong. It develops robotic femtosecond laser systems for refractive cataract surgery, focusing on astigmatism management and visual outcomes. The company's flagship ALLY system is designed to automate key steps in cataract procedures, including corneal incisions, capsulotomy, and lens fragmentation. LENSAR cites clinical data and surgeon endorsements, including Kerry Solomon, MD, as part of its Medical Advisory Board. Its technology competes in the robotic cataract surgery market alongside devices from Johnson & Johnson and Alcon. LENSAR markets its systems to ophthalmology clinics and hospitals globally, with a known presence in North America and Asia. The company promotes efficiency gains and patient outcomes as core value propositions. No recent operational events or team size were disclosed. LENSAR operates as a pure-play medical device firm, not a family office or asset manager. Its structure is that of a publicly-reportable manufacturer, with no investment or capital deployment functions disclosed.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Orlando
Corporate office
2800 Discovery Drive, Orlando, FL 32826, United States
Additional offices
Irvine, CA, United States · Hong Kong
Principals
Kerry Solomon
Medical Advisory Board Member
Sector focus
Frequently asked questions
What does LENSAR do with its capital?
LENSAR operates as a medical device manufacturer, not an investment firm. It develops and sells robotic cataract laser systems. Its capital is deployed into R&D, manufacturing, and commercial operations.
Who are LENSAR's known competitors?
LENSAR competes with Johnson & Johnson (via its femtosecond laser platform) and Alcon (LenSx laser). The robotic cataract surgery market also includes Ziemer Ophthalmic Systems.
How does LENSAR generate revenue?
LENSAR sells its ALLY and earlier LENSAR laser systems to hospitals and surgery centers. It likely also generates recurring revenue from consumables, service contracts, and software upgrades.
Is LENSAR associated with a family office?
No. LENSAR is a standalone medical technology company with no disclosed family office affiliation. It appears to be a public or private corporation based on its corporate structure.
What clinical outcomes does LENSAR claim?
LENSAR cites data on file from 2024 and a study by Orr MG (2021) comparing astigmatism correction rates using its system versus intraoperative aberrometry.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: